---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-001909"
form_type: "8-K"
ticker: "ZVRA"
cik: "0001434647"
company_name: "ZEVRA THERAPEUTICS, INC."
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T19:57:13.471846+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Zevra Therapeutics appoints Alvin Shih, M.D. to board of directors

## Summary
- Dr. Alvin Shih appointed as Class III director effective January 20, 2024.
- Shih has rare disease experience, former COO of Pfizer's Rare Disease Research Unit.
- Initial option grant of 58,800 shares vesting over 3 years, annual retainer $40,000.
- Shih will receive additional option of 39,200 shares annually while serving on board.
- No family relationships or transactions requiring disclosure under Item 404(a).

## SEC filing metadata
- accession: 0001437749-24-001909
- form_type: 8-K
- ticker: ZVRA
- cik: 0001434647
- company_name: ZEVRA THERAPEUTICS, INC.
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434647/000143774924001909/0001437749-24-001909-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434647/000143774924001909/zvra20240112_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-001909
- JSON: https://secwatch.observer/filing/0001437749-24-001909.json
- Plain text: https://secwatch.observer/filing/0001437749-24-001909.txt

## Key facts
- Executive change
  Alvin Shih, M.D. was appointed as director at ZEVRA THERAPEUTICS, INC..
  - Action: appointed
  - Role: director
  source text: On January 20, 2024, the board of directors (the “Board”) of Zevra Therapeutics, Inc. (the “Company”) appointed Alvin Shih, M.D. to serve as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434647/000143774924001909/0001437749-24-001909-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.